OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
BCLAF1 binds SPOP to stabilize PD-L1 and promotes the development and immune escape of hepatocellular carcinoma
Zongdong Yu, Xiang Wu, Jie Zhu, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 10
Zongdong Yu, Xiang Wu, Jie Zhu, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 10
Showing 10 citing articles:
BCLAF1 drives esophageal squamous cell carcinoma progression through regulation of YTHDF2-dependent SIX1 mRNA degradation
Peipei Zhang, Weiguang Zhang, Xiaoqing Wang, et al.
Cancer Letters (2024) Vol. 591, pp. 216874-216874
Closed Access | Times Cited: 7
Peipei Zhang, Weiguang Zhang, Xiaoqing Wang, et al.
Cancer Letters (2024) Vol. 591, pp. 216874-216874
Closed Access | Times Cited: 7
Ubiquitin modification in the regulation of tumor immunotherapy resistance mechanisms and potential therapeutic targets
Zihang Hong, Furong Liu, Zhanguo Zhang
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 6
Zihang Hong, Furong Liu, Zhanguo Zhang
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 6
Bclaf1 Mediates Super-Enhancer-Driven Activation of POLR2A to Enhance Chromatin Accessibility in Nitrosamine-induced Esophageal Carcinogenesis
Xiangjun Zhou, X.E. Zhou, Jun Li, et al.
Journal of Hazardous Materials (2025), pp. 138218-138218
Closed Access
Xiangjun Zhou, X.E. Zhou, Jun Li, et al.
Journal of Hazardous Materials (2025), pp. 138218-138218
Closed Access
Decoding the Role of O-GlcNAcylation in Hepatocellular Carcinoma
Xinyu Zhou, Sirui Hang, Qingqing Wang, et al.
Biomolecules (2024) Vol. 14, Iss. 8, pp. 908-908
Open Access | Times Cited: 3
Xinyu Zhou, Sirui Hang, Qingqing Wang, et al.
Biomolecules (2024) Vol. 14, Iss. 8, pp. 908-908
Open Access | Times Cited: 3
Bclaf1 biomolecular condensates protect nuclear PTK2 from ubiquitin-proteasome system promoting cardiomyocyte survival during oxidative stress
Isabela Aparecida Moretto, Beatriz Rodrigues, Pedro Víctor-Carvalho, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Isabela Aparecida Moretto, Beatriz Rodrigues, Pedro Víctor-Carvalho, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Plasma protein levels and hepatocellular carcinoma: a Mendelian randomization study with drug screening implications
Longhui Xie, Dekun Song, Jianwei Lan, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Longhui Xie, Dekun Song, Jianwei Lan, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Crosstalk between O-GlcNAcylation and ubiquitination: a novel strategy for overcoming cancer therapeutic resistance
Kai Sun, Yuan Zhi, Wenhao Ren, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 2
Kai Sun, Yuan Zhi, Wenhao Ren, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 2
Sorbaria sorbifolia flavonoid derivative induces mitochondrial apoptosis in human hepatoma cells through Bclaf1
Jiaxin Chen, Hao-Yi Cheng, Chunhua Bai, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Jiaxin Chen, Hao-Yi Cheng, Chunhua Bai, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Strategic advancement of E3 ubiquitin ligase in the management of hepatocellular carcinoma
Yangyang Miao, Shun‐Yi Wang, Jiahao Zhang, et al.
Medical Oncology (2024) Vol. 41, Iss. 7
Closed Access
Yangyang Miao, Shun‐Yi Wang, Jiahao Zhang, et al.
Medical Oncology (2024) Vol. 41, Iss. 7
Closed Access
Recent Advances in Developing Targeted Protein Degraders
Binbin Cheng, Hongqiao Li, Xiaopeng Peng, et al.
European Journal of Medicinal Chemistry (2024) Vol. 284, pp. 117212-117212
Closed Access
Binbin Cheng, Hongqiao Li, Xiaopeng Peng, et al.
European Journal of Medicinal Chemistry (2024) Vol. 284, pp. 117212-117212
Closed Access
